It is tempting to speculate that the high degree of ariability in the steady-state pharmacokinetics of hydroxychloroquine may explain why inconsistency in clinical improement is found in patients with pSS taking hydroxychloroquine, as it is possible that
It is tempting to speculate that the high degree of ariability in the steady-state pharmacokinetics of hydroxychloroquine may explain why inconsistency in clinical improement is found in patients with pSS taking hydroxychloroquine, as it is possible that
这是个具有吸引力的推测，稳态药动学中羟氯喹的高可变性能解释为什么使用羟氯喹的患者临床的改善不一致，同样有可能，仅仅那些既具有高水平的唾液胆碱酯酶活性有具有高的羟氯喹血药浓度的患者才显示唾液流量的升高【12，14】。